Regenxbio (RGNX) EBT Margin Growth (1y) (2015 - 2025)
Regenxbio (RGNX) EBT Margin Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn | 64,489.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 64,489.00 |
| Sep 30, 2025 | 2,815.00 |
| Jun 30, 2025 | -8,431.00 |
| Mar 31, 2025 | 48,602.00 |
| Dec 31, 2024 | -3,056.00 |
| Sep 30, 2024 | -3,441.00 |
| Jun 30, 2024 | 11,312.00 |
| Mar 31, 2024 | -13,356.00 |
| Dec 31, 2023 | -98,650.00 |
| Sep 30, 2023 | 7,074.00 |
| Jun 30, 2023 | -15,190.00 |
| Mar 31, 2023 | -289.00 |
| Dec 31, 2022 | 62,591.00 |
| Sep 30, 2022 | -9,492.00 |
| Jun 30, 2022 | 5,276.00 |
| Mar 31, 2022 | -8,001.00 |
| Dec 31, 2021 | 26,596.00 |
| Sep 30, 2021 | -19,868.00 |
| Jun 30, 2021 | -5,476.00 |
| Mar 31, 2021 | -3,857.00 |